Global Wellness Times
SEE OTHER BRANDS

Global take on healthcare and wellness news

Global Wellness Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.

Press releases published on May 7, 2025

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

CHICAGO, May 07, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

CogniStrong Under Review: The Brain Health Supplement Formulated Around a Memory Loss Discovery

CogniStrong Under Review: The Brain Health Supplement Formulated Around a Memory Loss Discovery

New York, May 07, 2025 (GLOBE NEWSWIRE) -- In This Article, You’ll Discover: The growing demand for brain health support supplements among adults of all ages Common causes of cognitive decline, including stress, poor sleep, and nutritional gaps Why memory …

Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

Eupraxia Pharmaceuticals to Host Virtual KOL Event to Discuss the Phase 1b/2a RESOLVE Study of EP-104GI for the Treatment of Eosinophilic Esophagitis (EoE) on May 9, 2025

VICTORIA, British Columbia, May 07, 2025 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary DiffuSphere™ technology designed to …

Registration Now Open for Questex’s Broadband Nation Expo – The Nation’s Premier Event for End-to-End Broadband Deployment

Registration Now Open for Questex’s Broadband Nation Expo – The Nation’s Premier Event for End-to-End Broadband Deployment

Third Annual Event Convenes November 17-19, 2025 in Orlando, FL; Register at https://www.broadbandnationexpo.com/register NEW YORK, May 07, 2025 (GLOBE NEWSWIRE) -- Questex’s Broadband Nation Expo today announces that registration is officially open for …

Pilly Labs Turmeric Gummies Reviewed: The Tasty Turmeric-Rich Gummy Edibles Difference

Pilly Labs Turmeric Gummies Reviewed: The Tasty Turmeric-Rich Gummy Edibles Difference

Chicago, May 07, 2025 (GLOBE NEWSWIRE) -- Turmeric has long been celebrated for its wellness-promoting properties. Many people turn to turmeric supplements to support joint health, reduce inflammation, and boost overall well-being. However, traditional …

Boing City Expands Water Slide Rentals in Mustang, OK for Summer 2025

Boing City Expands Water Slide Rentals in Mustang, OK for Summer 2025

Mustang families can now enjoy enhanced water slide rental options from Boing City, a local favorite owned by Nick Hibdon. MUSTANG, OK, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Boing City, a locally owned and operated inflatable rental company, …

Silver Palace Inc. Introduces New Sterling Silver Jewelry for Mother’s Day Gifts

Silver Palace Inc. Introduces New Sterling Silver Jewelry for Mother’s Day Gifts

Silver Palace Inc. is offering discounts on the newly launched Mother's Day special silver jewelry. LOS ANGELES, CA, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- Silver Palace Inc. has launched its Mother’s Day special silver jewelry collection, …

Yaqrit 的 HE 候选药物进入 3 期试验阶段并在 EASL 上展示了相关支持数据

Yaqrit 的 HE 候选药物进入 3 期试验阶段并在 EASL 上展示了相关支持数据

经 FDA 批准用于肝性脑病 3 期试验的一种改进型疾病分期工具,适用于静脉注射氨清除剂(YAQ006)。 口服氨清除剂(YAQ007)用于预防 HE 复发的剂量反应数据 氨清除剂作用机制的体内验证凸显与 TLR-4 拮抗剂(YAQ005)的潜在协同作用 伦敦, May 08, 2025 (GLOBE NEWSWIRE) -- Yaqrit 是一家聚焦临床后期阶段的公司,致力于开发治疗晚期肝病的救命疗法。本周,在 5 月 7 日至 10 日于阿姆斯特丹举行的欧洲肝脏研究协会(EASL …

The Preventive Measures Foundation Hosts the 9th Annual 'A Million Steps to Mental Health Awareness Walk'

The Preventive Measures Foundation Hosts the 9th Annual 'A Million Steps to Mental Health Awareness Walk'

Bringing the Lehigh Valley together to raise $25,000 for mental wellness grants and support services through an empowering community walk. ALLENTOWN, PA, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- The Preventive Measures Foundation (TPMF) invites …

Bee Line Team Members Earn CHEST Certification, Reinforcing Company’s Commitment to Healthcare Cleaning Excellence

Bee Line Team Members Earn CHEST Certification, Reinforcing Company’s Commitment to Healthcare Cleaning Excellence

Bee Line is proud to announce that five of its team members have earned the prestigious (T-CHEST) designation. CHICAGO, IL, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- Bee Line, a leading provider of healthcare-focused commercial cleaning services, …

Child-Resistant Bottles Market to Hit USD 5 Billion by 2035, Driven by Safety Demand in Pharma Sector | FMI

Child-Resistant Bottles Market to Hit USD 5 Billion by 2035, Driven by Safety Demand in Pharma Sector | FMI

Child-resistant bottles in the USA grow due to pharma needs for safe liquid drug packaging, driven by chronic illnesses and strict FDA regulations. NEWARK, DE, UNITED STATES, May 7, 2025 /⁨EINPresswire.com⁩/ -- The child resistant bottles market sales are …

Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Press release: SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM Ghent, Belgium, 7 May 2025 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in …

Recludix Pharma Presents Preclinical Data on First-in-Class BTK SH2 Domain Inhibitor Demonstrating Powerful BTK Inhibition, Exceptional Selectivity, and Encouraging Efficacy in a Model of Chronic Spontaneous Urticaria

Recludix Pharma Presents Preclinical Data on First-in-Class BTK SH2 Domain Inhibitor Demonstrating Powerful BTK Inhibition, Exceptional Selectivity, and Encouraging Efficacy in a Model of Chronic Spontaneous Urticaria

-- Bruton’s tyrosine kinase (BTK) SH2 inhibitor reduced skin inflammation in a clinically-relevant model of chronic spontaneous urticaria (CSU) -- BTK inhibition through the SH2 domain results in greater selectivity as compared to BTK tyrosine kinase …

Brunswick Corporation Declares Quarterly Dividend

Brunswick Corporation Declares Quarterly Dividend

METTAWA, Ill., May 07, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Brunswick Corporation (NYSE: BC) today declared a quarterly dividend on its common stock of $0.43 per share. The dividend will be payable on June 13, 2025, to shareholders of record …

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly

Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya vaccine …

Valneva fait un point suite à l'annonce de l'agence européenne des médicaments sur l'utilisation d'IXCHIQ® chez les personnes âgées

Valneva fait un point suite à l'annonce de l'agence européenne des médicaments sur l'utilisation d'IXCHIQ® chez les personnes âgées

Saint Herblain (France), le 07 mai 2025 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, a annoncé aujourd'hui que l’agence européenne des médicaments (EMA) a entamé une revue du vaccin vivant atténué contre le …

Minister of Education announces CPR, AED, and Opioid Overdose Response Training now mandatory part of the provincial curriculum

Minister of Education announces CPR, AED, and Opioid Overdose Response Training now mandatory part of the provincial curriculum

CHARLOTTETOWN, Prince Edward Island, May 07, 2025 (GLOBE NEWSWIRE) -- The Advanced Coronary Treatment (ACT) Foundation joined the Government of Prince Edward Island (PEI), and its partners at Colonel Gray Senior High School to launch the lifesaving CPR, …

Le ministre de l'Éducation annonce que la formation en RCR, DEA et en intervention en cas de surdose d'opioïdes sera désormais obligatoire dans le programme scolaire provincial

Le ministre de l'Éducation annonce que la formation en RCR, DEA et en intervention en cas de surdose d'opioïdes sera désormais obligatoire dans le programme scolaire provincial

CHARLOTTETOWN, Île-du-Prince-Édouard, 07 mai 2025 (GLOBE NEWSWIRE) -- La Fondation Advanced Coronary Treatment (ACT) s’est jointe au gouvernement de l’Île-du-Prince-Édouard (Î.-P.-É.) et à ses partenaires de l’école secondaire Colonel Gray Senior High …

Aki Yorihiro Discusses Fast Motion Shaft Breakthrough on TechMediaWire Podcast

Aki Yorihiro Discusses Fast Motion Shaft Breakthrough on TechMediaWire Podcast

AUSTIN, Texas, May 07, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The TechMediaWire …

Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology

Arcutis Announces Publication of Positive Data from ARRECTOR Trial Evaluating ZORYVE® (roflumilast) Foam 0.3% in Individuals with Psoriasis in Journal of American Medical Association Dermatology

Once-daily, investigational ZORYVE foam 0.3%, rapidly improved psoriasis of the scalp and body, including itch, when used as a monotherapy 66.4% of individuals treated with ZORYVE foam achieved Scalp-Investigator Global Assessment (S-IGA) Success at Week 8 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service